Side-by-side comparison of AI visibility scores, market position, and capabilities
H1 is the leading healthcare provider data platform; raised $305M+ total (Series C led by Altimeter); acquired Ribbon Health (Jan 2025) and Veda Data Solutions (Jun 2025) to build end-to-end provider data infrastructure.
H1 is a healthcare data technology company building the industry's most comprehensive provider data platform, serving life sciences companies, health plans, hospitals, and digital health organizations. Founded in 2017 and headquartered in New York, H1 aggregates data on millions of healthcare professionals worldwide — including clinical expertise, publication records, trial participation, prescribing patterns, and network affiliations — and makes this data accessible through a unified platform and API layer. Life sciences customers use H1 to identify key opinion leaders, optimize clinical trial site selection, and target medical outreach with precision; health systems and payers use it for directory management, credentialing, and network adequacy analysis.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.